Dear Jeffrey Benz, Esq., SK3 Group, Inc. Executive V.P.

New Post Public Reply Private Reply Replies (4) Message Board
bellsandwhistles
Dear Jeffrey Benz, Esq., SK3 Group, Inc. Executive V.P. & General Legal Counsel:

As a large stockholder of SK3 Group, Inc. (SKTO) and ardent fan of Berkeley Bio in light of the singularly important work the GoldNApel team does, I bring to your attention issues of crucial interest in regard to Alternative Energy Partners, Inc. (AEGY).

The first issue is a questionable statement made by CEO Mario Barrera in an AEGY 8-K submitted to SEC re Michael Gelmon and Alberta Securities Commission's Cease Trade order. The second issue is unbridled if not reckless AEGY share dilution. The third is control issues at AEGY and apparent duplicity and sleight of hand in AEGY FL corporate filings. 

Given the 03/14/2014 announcement of a contemplated merger of SKTO and AEGY, the state of the financial health and the integrity of AEGY are of obvious concerns vis a vis SKTO which boasts a positive balance sheet and superior prospects for growth.

It is therefore vital that an SEC examination of AEGY pursuant to a merger shows no serious defects in said firm lest not only the merger be denied but also the firm be jeopardized and taint SKTO. As you well know, the SEC has developed a lower tolerance for abuse of public trust and markets by OTC tickers. To add, FINRA issued a warning on the MMJ sector in August 2013. Therefore, prudence and circumspection must be the order of the day.

Share Dilution

According to recent AEGY SEC filings:

AEGY (the "Company") has an accumulated deficit of $10,247,626, and a working capital deficit of $1,761,077 as of Jan 31, 2014.

In the the six months ending January 31, 2014, the Company issued 1,339,318,962 common shares resulting in 2,164,853,983 outstanding shares as of January 31, 2014.

As of March 19, 2014, there were 3,549,927,718 shares of common stock outstanding.

These data also show that the pace of dilution from August 1, 2013 to March 19, 2014 was 363 million common stock issued per month. 

Even more disturbingly, these data show AEGY issued 1.385 billion common shares in just 32 business days (not counting NYSE holiday) for an average of 43.3 million shares issued every business day from Feb 1 - March 19 inclusive.

Assuming the latter pace of dilution, an additional 476 million common shares of AEGY would have been issued by today's date April, 3, 2014.

Gelmon and Alberta Securities Commission Cease Trade

On 02/10/2014, AEGY presented to the SEC Form 8-K signed by AEGY CEO Mario Barrera. The purpose of the 8-K was to report and explain a material event, i.e., a "Cease Trade" order issued by the Alberta Securities Commission in Canada against AEGY.

In said 8-K, CEO Barrera protested the Cease Trade order and explained that, "The sole apparent basis for the Alberta action, whether or not enforceable against Registrant (i.e., AEGY), was that Michael Gelmon was a director of Registrant from January 2013 to early May, 2013. Mr. Gelmon resigned all positions with the Company as of early May, 2013, long before the 'cease trade order' was issued and is not now affiliated in any way with Registrant."

The aforesaid statement CEO Barrera made to the SEC is questionable in light of the following: 

In the latest AEGY 10-Q filed 03/24/14 for period ending 01/31/14 and signed by Mario Barrera as CEO and John F. Burke as Consulting Principal Accounting Officer appear the following statements:

1) "We (i.e., AEGY) have entered into a consulting agreement effective December 31, 2012 with Novation Consulting Services, Inc., which remains in effect."

2) "Mario Barrera currently is our Chairman, President and CEO and sole officer. He is not an employee of the company and is not paid as an employee. Currently, we have no paid employees, full or part-time, and rely on paid consultants to provide necessary services."

According to FL corporate filings, Novation Consulting Service is peopled by John F. Burke as Treasurer and Michael Gelmon as Director, President, and Secretary. See attachment #1.

John F. Burke is an officer of said Novation Consulting Services, Inc. Burke is also an officer of AEGY and co-signs the AEGY SEC filings as "Consulting Principal Accounting Officer," obviously a remunerated consultant.

However, according to AEGY CEO Mario Barrera in the 8-K: "Mr. Gelmon resigned all positions with the Company as of early May, 2013, long before the 'cease trade order' was issued and is not now affiliated in any way with Registrant (AEGY)."

One can see the problem here:

In brief, Michael Gelmon is President, Director, and Secretary of the same Novation Consulting Services, Inc. that "provide necessary services" to AEGY. And, yet, AEGY CEO Mario Barrera has signed before the SEC in an 8-K that Michael Gelmon is not affiliated in any way with AEGY.

Control Issues and Apparent Duplicity

The attachments (no. 2 &  3) speak for themselves. Compare March 25, 2014 with March 28, 2014 filings. Who really runs AEGY? The SEC will ask those hard questions in light of these filings when it inspects them pursuant to a merger application. Please note that Robert Hipple is listed as an AEGY officer in the 03/25/2014 filing despite a five year O&D bar by SEC still in force.

There is also the issue that John F. Burke's firm "MI Financial Services" of Florida-- registered agent of AEGY -- doesn't exist in the FL online corporate data base, sunbiz.org

Thank you for your close attention in these matters.

Attachment #1


Attachment #2


Attachment #3

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading

Top 5 Most Recently Viewed Articles

New Tariffs on Chinese Imports: Impacts and Industry Reactions

Updated Category News Views 209

Recent Tariff Increases on Chinese Goods The Biden administration has recently put into place notable tariff increases on a range of imports from China. This initiative is aimed at strengthening protection for essential American industries. One of the standout changes is a hefty 100% tariff on electric vehicles brought in from China. This move is intended to support...

Continue Reading
P2P Group Strengthens Leadership with Expert Advisory Board

Updated Category News Views 86

P2P Group Forms a High-Quality Advisory Board P2P Group Limited is thrilled to announce the creation of a new Advisory Board, which aims to enhance strategic planning and drive innovation within the organization. Introducing the Newest Advisory Member The board welcomes Alex Makrodimitras, a highly experienced professional with more than 22 years in Canadian Special...

Continue Reading
Crocs Overshadows Expectations with Impressive Q4 Earnings

Updated Category News Views 212

Crocs Surpasses Earnings Expectations in Q4 Crocs recently announced impressive quarterly earnings of $2.29 per share, which significantly exceeded the analyst consensus estimate of $1.90 per share. In addition, the company’s sales for the quarter reached $957.64 million, outpacing the market's expectation of $922.33 million. These results have provoked optimistic...

Continue Reading
Discoveries in Oncology: Ascentage Pharma's Path Forward

Updated Category News Views 253

Exciting Developments from Ascentage Pharma Presentations Ascentage Pharma, a leading biopharmaceutical firm, recently announced significant progress in their clinical studies, particularly focusing on innovative cancer treatments. At the upcoming ASCO Annual Meeting, the company plans to showcase findings related to their two prominent drug candidates: lisaftoclax and...

Continue Reading